These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9831633)

  • 1. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins.
    Montine KS; Bassett CN; Ou JJ; Markesbery WR; Swift LL; Montine TJ
    J Lipid Res; 1998 Dec; 39(12):2443-51. PubMed ID: 9831633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
    Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
    Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
    Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
    J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.
    Fukuyama R; Mizuno T; Mori S; Yanagisawa K; Nakajima K; Fushiki S
    Eur Neurol; 2000; 43(3):161-9. PubMed ID: 10765057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
    Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
    J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.
    Lehtimäki T; Pirttilä T; Mehta PD; Wisniewski HM; Frey H; Nikkari T
    Hum Genet; 1995 Jan; 95(1):39-42. PubMed ID: 7814023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism.
    Ikewaki K; Rader DJ; Zech LA; Brewer HB
    J Lipid Res; 1994 Oct; 35(10):1809-19. PubMed ID: 7852858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific.
    Lovestone S; Anderton BH; Hartley C; Jensen TG; Jorgensen AL
    Neuroreport; 1996 Apr; 7(5):1005-8. PubMed ID: 8804040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease.
    Roses AD; Saunders AM; Corder EH; Pericak-Vance MA; Han SH; Einstein G; Hulette C; Schmechel DE; Holsti M; Huang D
    Arzneimittelforschung; 1995 Mar; 45(3A):413-7. PubMed ID: 7763336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
    Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
    Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease.
    Császár A; Kálmán J; Szalai C; Janka Z; Romics L
    Neurosci Lett; 1997 Jul; 230(3):151-4. PubMed ID: 9272683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3.
    Benvenga S; Cahnmann HJ; Rader D; Kindt M; Robbins J
    Endocrinology; 1992 Dec; 131(6):2805-11. PubMed ID: 1446618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of apolipoproteins E and A-I in cutaneous amyloids.
    Chang YT; Tsai SF; Wang WJ; Hong CJ; Huang CY; Wong CK
    Br J Dermatol; 2001 Sep; 145(3):422-7. PubMed ID: 11531831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
    Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
    Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
    Weidman SW; Ragland JB; Sabesin SM
    J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.